| "A Multinational, Prospective, Observational Study of theEffectiveness, Healthcare Resource Utilization and Costsin Patients with Rheumatoid Arthritis ReceivingBaricitinib, Targeted Synthetic or BiologicDisease-Modifying Therapies" |
Ongoing |
Baricitinib |
4 |
I4V-MCB009 |
Specialized Medical Center (Riyadh), Dr. Sulaiman Al-Habib Medical Group Takhassusi (Riyadh) |
| A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT PATIENTS RECEIVING DUPIXENT FOR ATOPIC DERMATITIS |
Ongoing |
DUPILUMAB |
4 |
OBS15990 |
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam) |
| A multicenter, multinational, prospective, observational study to describe the clinical outcomes in patients with Type 2 diabetes mellitus, treated with iGlarLixi fixed ratio combination (SOLIQUA®) before, during and after the period of Ramadan (SoliRam Study) |
Ongoing |
Soliqua® Solostar |
4 |
OBS16049 |
University District Hospital (Jeddah), Alzafer Hospital (Najran), Ghassan Najeeb Pharaon hospital (Jeddah) |
| Guidelines Oriented Approach to Lipid lowering Quality Enhancement Research Initiative (GOAL QuERI) International |
Ongoing |
any SFDA registered anti-hyperlipidemic product |
4 |
CHRC2019 |
King Fahd Armed Forces Hospital (Jeddah), King Fahd Military Medical Complex (Dhahran), King Abdullah Medical Complex (Jeddah), King Fahad Hospital (Jeddah), King Fahad Genaral Hospital (Medina), King Khaled General Hospital (Hafar Al Batin), Royal Commission Hospital Jubail |
| Vortioxetine effectiveness overview for the treated MDE patients in Saudi Arabia |
Ongoing |
BRINTELLIX 20 mg film-coated tablet/ BRINTELLIX 10 mg film-coated tablet |
4 |
18620N |
King Abdulaziz University Hospital (Jeddah), Saudi German Hospital (Jeddah), Dr. Erfan & Bagedo General Hospital (Jeddah), University Medical Center (Riyadh), Psych care Center (Riyadh), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Al Moosa Specialized Hospital (al ahsa), King Fahad Medical City (Riyadh), Almana Hospital (Dammam), King Abdullah Medical Complex (Jeddah), Jeddah psychiatric hospital, Elite Medical Complex (Makkah) |
| A multicentre non-interventional study to assess the real-world effectiveness of Ocrelizumab in patients with relapsing or primary progressive multiple sclerosis – The MuSicalE STUDY |
Ongoing |
Ocrelizumab (Ocrevus) |
4 |
MN39889 |
King Abdulaziz Medical City NG (Riyadh) |
| "Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP)" |
Ongoing |
• Ceftriaxone • Piperacillin Tazobactam • Azithromycin • Interferon β1-a • Hydrocortisone sodium suc.• Hydroxychloroquine • OSELTAMIVIR • Lopinavir-Ritonavir |
3 |
CT20/001/R |
King Abdulaziz Medical City NG (Riyadh) |
| A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19 |
Ongoing |
• Favipiravir• HYDROXYCHLOROQUINE SULPHATE |
3 |
RC20/174/R |
King Abdulaziz Medical City NG (Riyadh) |
| A Trial of Favipiravir in Adults with Mild Coronavirus Disease Covid-19 |
Ongoing |
Favipiravir |
3 |
RC20/220/R |
King Abdulaziz Medical City NG (Riyadh) |
| A National Collaborative Multicenter Phase II Study for Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 |
Ongoing |
Convalescent Plasma |
2 |
20-COVID-19-01M |
King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), King Abdulaziz Hospital NG (Al Ahsa), Prince Mohammad bin Abdulaziz Hospital NG (Medina), Qatif Central Hospital, Dammam Medical Complex, King Fahad Medical City (Riyadh), King Saud Medical City (Riyadh), King Abdullah Medical City (Makkah), Al-Noor Specialist Hospital (Makkah), King Abdullah Medical Complex (Jeddah), Ohud hospital (Medina), King Fahad Genaral Hospital (Medina), Aseer Central Hospital (Abha) |
